WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Seres Therapeutics earnings were $86.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MCRB earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$19.9M, down 160.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MCRB reported annual earnings of $136.0k, with -100.1% growth.

MCRB earnings history

Current Revenue
$0.0
Current Earnings
$86.0M
Current Profit Margin
0%

MCRB Return on Equity

Current Company
283.9%
Current Industry
-10%
Current Market
30.7%
MCRB's Return on Equity (283.9%)... subscribe to Premium to read more.
High Return on Equity Performance

MCRB undefined

Current Company
54.9%
Current Industry
-0.2%
MCRB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MCRB announces earnings.

MCRB undefined

Current Company
76.17%
Current Industry
6.4%
MCRB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MCRB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MCRB$99.15M$85.97MN/A$10.89
CHRS-$106.54M-$130.94MN/A-$1.13
ELDN-$4.27M-$5.02MN/A$0.05
GLSI-$17.99M-$17.99MN/A-$1.36
AGEN-$69.99M-$165.68MN/A-$7.05
View Top Biotech Stocks

Seres Therapeutics Earnings Reports & History FAQ

What were Seres Therapeutics's earnings last quarter?

On MCRB's earnings call on Invalid Date, Seres Therapeutics (NASDAQ: MCRB) reported Q2 2025 earnings per share (EPS) of -$2.27, up 47.7% year over year. Total MCRB earnings for the quarter were -$19.86 million. In the same quarter last year, Seres Therapeutics's earnings per share (EPS) was -$4.34.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.

Is Seres Therapeutics profitable or losing money?

As of the last Seres Therapeutics earnings report, Seres Therapeutics is currently profitable. Seres Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $85.97 million, a 153.03% decrease year over year.

What was MCRB's earnings growth in the past year?

As of Seres Therapeutics's earnings date in Invalid Date, Seres Therapeutics's earnings has grown year over year. MCRB earnings in the past year totalled $85.97 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.